Kristin Acosta
Family Medicine · Morgan City, LANPI 1942832407
Payments from drug & device makers
Across 348 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$788
- AstraZeneca$751
- Pfizer$540
- Lilly USA, LLC$529
- Novo Nordisk$414
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $1,199 |
| GSK | 50 | $788 |
| AstraZeneca | 49 | $751 |
| Pfizer | 27 | $540 |
| Lilly USA, LLC | 31 | $529 |
| Novo Nordisk | 26 | $414 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $324 |
| Esperion Therapeutics, Inc. | 13 | $218 |
| Hologic Sales And Service, LLC | 1 | $149 |
| Corium, LLC | 9 | $137 |
| Exact Sciences | 7 | $137 |
| Teva Pharmaceuticals USA, Inc. | 4 | $94 |
| Amgen | 6 | $88 |
| Boehringer Ingelheim | 6 | $88 |
| Silk Road Medical, Inc. | 1 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $57 |
| Johnson & Johnson | 3 | $45 |
| Novartis | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Abbott | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Bayer | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
| Corcept Therapeutics | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aptima$149
How this compares
$5,972 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 76 | $80,543 |
| OzempicSemaglutide | 53 | $51,520 |
| JardianceEmpagliflozin | 30 | $35,903 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $29,588 |
| TrulicityDulaglutide | 28 | $26,823 |
| EliquisApixaban | 19 | $10,820 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $10,730 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $10,257 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $10,124 |
| Spiriva RespimatTiotropium Bromide | 12 | $8,678 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,304 |
| Gabapentin | 291 | $3,572 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $2,574 |
| Humulin N KwikpenInsulin Nph Human Isophane | 12 | $2,155 |
| Testosterone Cypionate | 32 | $1,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $529 | $107,366104 claims |
| Novo NordiskOzempic | $414 | $51,52053 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $88 | $44,58142 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $788 | $39,84560 claims |
| PfizerEliquis | $540 | $10,82019 claims |
| AstraZenecaBreztri Aerosphere | $751 | $7,30411 claims |
| AbbVieSynthroid | $1,199 | $77218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Morgan City
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
- Kristen ThomasNew Orleans$361K
- Clint WilsonBossier City$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.